IHMRI affiliation

Theme:Diagnostics and therapeutics
Role:Theme Leader / Affiliated Stakeholder Advisory Panel (ASAP)
Level:IHMRI Senior Fellow

Research focus

  • Cancer metastasis biomarkers and therapeutics
  • The plasminogen activation system in tumour invasion and metastasis
  • Targeted drug development against biomarkers of cancer and inflammation

Research projects

Publications and funding

Memberships

  • Member of Editorial board of Current Drug Targets journal (ISSN: 1873-5592)
  • The American Society for Biochemistry and Molecular Biology
  • International Society of Fibrinolysis and Proteolysis
  • Metastasis Research Society
  • International Society for Thrombosis and Haemostasis

Other roles

CONCERT Deputy Director (T1/T2 Flagship)

Funded by CINSW with contributions from UNSW, WSU, UOW, ISLHD and Ingham Institute

concert.org.au

Follow CONCERT on Twitter

IHMRI research team

Research fellows

Dr Benjamin Buckley T: +61 2 4221 3947 | E: bbuckley@uow.edu.au
Dr Jay Perry T: +61 2 4221 3947 | E: jayp@uow.edu.au

Research assistants

Elahe Minaei T: +61 2 4221 5427 | E: eminaei@uow.edu.au

PhD candidates

Umar Ali Biochemical, cell biology and pharmacological evaluation of novel 6-substituted amiloride and 6-substituted hexamethyleneamiloride (HMA) derivatives as new agents for inflammatory disease
Jordan Cater Investigations of the roles of pregnancy zone protein (PZP) and plasminogen activator inhibitor type-2 (PAl-2) in extracellular proteostasis
Ashna Kumar Pharmacological profiling of amiloride analogues
Gary Tincknell Molecular and Clinical Biomarker assessment of gastric cancer